Persistent ductus arteriosus. Patent ductus arteriosus
Conditions
Interventions
Intervention 1: In the intervention group, an intravenous acetaminophen made by Iran Exir Company at a dose of 10 mg/kg is injected each 12 hours. Intervention 2: In the control group, for two days, i
Sponsors
Vice chancellor for research, Mazandaran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
No minimum to 3 Days
Inclusion criteria
Inclusion criteria: Preterm infants with gestational age <32 weeks
Exclusion criteria
Exclusion criteria: Lethal anomalies Congenital heart diseases Existing patent ductus arteriosus
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Opening of patent ductus arteriosus. Timepoint: 1 to 3 days after birth. Method of measurement: Echocardiography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Intraventricular hemorrhage. Timepoint: 1 to 3 days after birth. Method of measurement: Brain sonography.;Gastrointestinal bleeding. Timepoint: 1 week. Method of measurement: Clinical examination.;Necrotizing enterocolitis. Timepoint: 1 week. Method of measurement: Clinical examination and stool exam.;Oliguria. Timepoint: 1 week. Method of measurement: Measurement of urine volume.;Pulmonary hemorrhage. Timepoint: 1 week. Method of measurement: Clinical examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNasim Meh
Mazandaran University of Medical Sciences
Outcome results
None listed